SCRI Oncology Partners Tennessee Oncology (3) — Nashville, Tennessee

SCRI Oncology Partners Tennessee Oncology (3) is a clinical research site located in Nashville, Tennessee, United States 37203.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

SCRI Oncology Partners Tennessee Oncology (3) has participated in 1 clinical trials.

Therapeutic areas: Advanced Metastatic Breast Cancer.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for SCRI Oncology Partners Tennessee Oncology (3)?

SCRI Oncology Partners Tennessee Oncology (3) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has SCRI Oncology Partners Tennessee Oncology (3) conducted?

SCRI Oncology Partners Tennessee Oncology (3) has 1 clinical trials on record. Their work covers Advanced Metastatic Breast Cancer.

Is SCRI Oncology Partners Tennessee Oncology (3) accredited by Crixeo Health?

SCRI Oncology Partners Tennessee Oncology (3) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about SCRI Oncology Partners Tennessee Oncology (3)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.